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Abstract
Myopia affects well over 30% of adult humans globally. However, the underlying physiological mechanism is little
understood. This study tested the hypothesis that ocular growth and refractive compensation to optical defocus can be
controlled by manipulation of potassium and chloride ion-driven transretinal fluid movements to the choroid. Chicks were
raised with +/210D or zero power optical defocus rendering the focal plane of the eye in front of, behind, or at the level of
the retinal photoreceptors respectively. Intravitreal injections of barium chloride, a non-specific inhibitor of potassium
channels in the retina and RPE or bumetanide, a selective inhibitor of the sodium-potassium-chloride cotransporter were
made, targeting fluid control mechanisms. Comparison of refractive compensation to 5mM Ba
2+ and 10
25 M bumetanide
compared with control saline injected eyes shows significant change for both positive and negative lens defocus for Ba
2+
but significant change only for negative lens defocus with bumetanide (Rx{10D
SAL ~{8:6+:9D; Rx{10D
Ba2z ~{2:9+:9D;
Rx{10D
Bum ~{2:9+:9D; Rxz10D
SAL ~z8:2+:9D; Rxz10D
Ba2z ~z2:8+1:3D; Rxz10D
Bum ~z8:0+:7D). Vitreous chamber depths
showed a main effect for drug conditions with less depth change in response to defocus shown for Ba
2+ relative to Saline,
while bumetanide injected eyes showed a trend to increased depth without a significant interaction with applied defocus.
The results indicate that both K channels and the NKCC cotransporter play a role in refractive compensation with NKCC
blockade showing far more specificity for negative, compared with positive, lens defocus. Probable sites of action relevant
to refractive control include the apical retinal pigment epithelium membrane and the photoreceptor/ON bipolar synapse.
The similarities between the biometric effects of NKCC inhibition and biometric reports of the blockade of the retinal ON
response, suggest a possible common mechanism. The selective inhibition of refractive compensation to negative lens in
chick by loop diuretics such as bumetanide suggests that these drugs may be effective in the therapeutic management of
human myopia.
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Introduction
Myopic eyes in humans and animals are larger in axial
dimensions and hence in volume than emmetropic eyes, while
refractively hyperopic eyes are smaller overall than emmetropic
eyes of the same age. The changes in axial dimensions and
refraction are directly related to changes in vitreous chamber
depth [1]. Refractive changes, approximately equal to the strength
of blur experienced, can be induced in hatchling chicks with a few
days of negative or positive optical defocus (reviewed [2]). Vitreal
depth changes are also accompanied by inverse changes in the
thickness of the choroidal vasculature such that optical defocus
with negative lenses or form deprivation leads to increased vitreal
depth and dramatic thinning of the choroid, while optical defocus
with positive lenses is associated with shorter vitreous chamber
dimensions and thickening of the choroid. How this balance
between growth and refractive demand is achieved is not well
understood. ‘‘Stop’’ and ‘‘Go’’ growth factors [3], choroidal
control of the refractive plane [4] and scleral sculpting [5] have all
been proposed as potential mechanisms of ocular growth.
However, the problem of how the fluid necessary for ocular
dimensional changes is accumulated or dispersed is only addressed
by our theory of RPE/Mu ¨ller cell controlled ionically driven trans-
retinal fluid flow between vitreous chamber and the choroidal
lymphatics [6].
Crewther [6] hypothesized that the increase in vitreous volume
associated with form deprivation myopia was due to a reduction in
the rate of the normal fluid outflow across the retinal pigment
epithelium (RPE) from the retina to the choroid, with retention in
the vitreous chamber. This model is based on four principles. The
first, that the vitreous chamber and choroid act as fluid reservoirs
in the eye, is supported by much previous ultrastructural research
[7,8]. The second, that the RPE controls movement of fluid
between these reservoirs is also well supported by in vitro and in vivo
physiological research (reviewed [9,10]). The model further poses
that reduction of temporal modulation of light under an occluder
(a condition associated with myopia and abnormal ocular
elongation) leads to reaccumulation of potassium (K) ions in the
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been reported [15]. The last principle–that fluid exchange across
the RPE is causally driven by the refractive error signal, is yet to be
proven. The proposed outer retinal/RPE site of determination of
defocus and deprivation sensing is supported by various experi-
ments that have interfered with inner retinal function without
preventing refractive/growth compensation. These include optic
nerve section [16], tetrodotoxin (TTX) elimination of spiking
sodium channels (ganglion cells and some amacrines) [16] and
NMDA inhibition of third order retinal neurons [17].
Elemental X-ray microanalysis of myopic form deprived (FD)
chick retinas has shown an increase in atomic abundance of K,
localized to the vicinity of the sub-retinal space (SRS), RPE and
photoreceptor outer segments, and a generalized increase in the
abundance of Na and Cl across the retina, RPE and choroid.
Following the termination of FD, the high subretinal K abundance
rapidly reduced to levels below normal until refractive recovery 5
days later [15], while Na and Cl abundances took several days to
return to normal levels. Such increased abundance of potassium in
theSRSleadstoreducedSRSvolumeand reducesthemovementof
fluid across the RPE in in vitro preparations [18]. This implies that
more of the fluid being synthesized in the retina as a result of
glycolysis [19,20] must remain in the extracellular space of inner
retina or be transferred into the vitreous via the Mu ¨ller cells. As the
ultrastructural appearance of the FD retina is one of hyperosmo-
larity rather than edema, the latter alternative, of fluid movement
into the vitreous, is the likely outcome. This conclusion is supported
by the fact that less than 30min of normal visual experience
following occluder removal leads to a substantial increase in
choroidal thickness and the appearance of edema beginning to
move across the retina from the vitreous towards the choroid [21].
Fluid movements across the RPE to the choroidal blood supply
are controlled by the ionic channels, cotransporters and symporters
of the apical and basal membranes of the RPE. In vitro eye cup
studies demonstrate that numerous ionic species (K
+,N a
+,C a
2+,
H
+,C l
2, HCO3
2, as well as lactate) affect subretinal space fluid
dynamics (reviewed [22]). However, due to the fact that to date,
only K, Na and Cl abundance have been experimentally associated
with myopia [15,21], and given that Crewther’s [6] hypothesis
related myopia to the activity of the inwardly rectifying K channels
and the sodium potassium 2-chloride symporter (NKCC1) on the
apical membrane of the RPE, we have chose to focus this study on
potassium and the way in which potassium channels and cation-
chloride transporters, particularly the sodium potassium 2-chloride
symporter (NKCC1) on the apical membrane of the RPE, are
intimately involved in the growth response to defocus.
NKCC1 belongs to the cation-chloride cotransporter family,
which mediates the coupled movement of Na, K and two Cl ions
in strict ratio across the plasma membrane of cells. NKCC1
transport is electroneutral, with the driving force for ion influx
being in part supplied by the inward Na
+ gradient and maintained
by Na/K-ATPase [23]. These channels, symporters and exchang-
ers, driven by alterations in K concentration, modulate fluid
transfer by controlling the absorption and secretion of chloride
[22], and hence water transport, via the cotransporters themselves
[24] and in concert with aquaporin channels [19]. Sulfamoyben-
zoic acid loop diuretics such as bumetanide can compete with Cl
2
for the second chloride binding site and thus inhibit NKCC1
function [23]. In fact when the kidney isoform of the NKCC
cotransporter (NKCC2) is inhibited by bumetanide, a large
increase in urine flow, nearly isosmotic with plasma, is observed,
regardless of the hydration state of the individual. Thus, under
diuretic treatment, an individual loses the ability to excrete either a
concentrated or a dilute urine. The NKCC2 isoform, found in the
thick ascending loop of Henle of the kidney, appears to rely on the
recycling of K ions through luminal K channels for its normal
operation, as barium blockade of the potassium channels
significantly reduces Na reabsorption [25].
Cation-chloride transporters are found not only on epithelial
cells, but also across the retina. Vardi et al [26] used antibodies to
mGluR6 to label the metabotropic glutamate receptor at the
photoreceptor ON-bipolar synapse, and showed that antibodies to
NKCC1 but not KCC2 (potassium chloride symporter receptor
protein) co-localize with the glutamate receptor. Similarly, anti-
calbindin, that selectively labels an OFF-bipolar subclass, co-
localizes with KCC2 but not NKCC1 immunoreactivity at the flat
synapses of the photoreceptor OFF-bipolar interface. Thus KCC2
is expressed wherever the chloride equilibrium potential ECl,Erest
(resting potential), whereas NKCC1 is expressed wherever
ECl.Erest (ON bipolar dendrites). KCC2 was also found to be
expressed on the OFF bipolar dendrites, ganglion cell and bipolar
axons whereas NKCC1 antibodies typically labelled horizontal
cells as well as the ON bipolar dendrites [26]. Thus, bumetanide,
which is a selective blocker of NKCC1 may also alter retinal
function by blocking the cation-chloride uptake at the ON-bipolar
dendrites (and horizontal cells). Bumetanide also eliminates the
directional responses of directionally selective ganglion cells and
starburst amacrine cells [27,28].
Given the likelihood that myopia induced by lens defocus shares
many of the same mechanisms and ultrastructural changes as form
deprivation [21,29], it is probable that inhibiting potassium
movements in such retinae would interfere with defocus induced
refractive and growth changes, especially as apical potassium and
basal chloride appear to be strongly linked in the RPE [30]. The
RPE contains many different potassium channels. Early Ussing
chamber experiments demonstrated the presence of weak inwardly
rectifying potassium channels (Kir), with more recent research
delineating the likely presence of Kir7.1 and Kir4.1 subfamilies
(reviewed [22]). Despite their inwardly rectifying nature, the apical
channels are largely involved in recycling K
+ ions back to the SRS,
a process that occurs because in RPE cells the resting membrane
potential is more positive than the K equilibrium potential (EKeq),
resulting in outward K
+ currents. While Ba
2+ blocks these Kir
channels with different sensitivities, it is also a non-specific blocker
of voltage-gated and Ca
2+-activated K
+ channels [31–33]. Thus,
in the first experiment we tested this idea by investigating the
interaction of the non-selective potassium channel blocker Ba
2+
with the induction of refractive error by lens defocus.
Loop diuretics, by comparison, act to inhibit the cation-chloride
NKCC cotransporter, thus inhibiting the coordinated trans-
membrane movement of Na, K and Cl ions [23]. Thus, in a
second experiment, we tested the idea that if negative lens defocus
results in myopia and ocular elongation through a reduction in the
outflow of fluid across the RPE, then intravitreal injection of the
diuretic bumetanide would restore RPE fluid flow as evidenced by
relative suppression of abnormal vitreal chamber growth and
inhibition of myopia.
Results
Experiment 1: Potassium channels and refractive
compensation
Potassium channels were blocked via intravitreal injection of
barium chloride to a vitreal concentration of approximately 5mM.
Retinoscopy and ultrasonography demonstrated that while saline
injected eyes showed about 85% refractive compensation to the
applied defocus over the four days of rearing, barium suppressed
refractive compensation to both positive and negative lenses, but
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focused vision (0D group). A generally negative linear relationship
between refraction and vitreous chamber depth is clearly evident
in the data - across all lens groups and the two drug groups (Ba
2+,
SAL), the data fall along a main trend line (see Figure 1A). A
between group Analysis of Variance (ANOVA) (for Lens Defocus
(+10D, 0D, 210D) and Treatment (Ba
2+, Saline)) demonstrated a
significant main effect of Lens Defocus (F(2,59)=61.1, p,.0001)
but not of Treatment on ocular refraction (F(1,59)=0.98, p=.32).
A significant interaction between Lens Defocus and Treatment
was also observed (F2,59=16.2, p,.0001), - see Fig 1B. Post-hoc
tests showed the suppression of compensation to defocus by Ba
2+,
with significant refractive difference for both positive and negative
lenses compared with saline injected eyes (Fisher’s PLSD, p,.005)
(see Table 1).
Similarly, ANOVA on vitreous chamber length showed the
same pattern with significant main effect for Lens (F(2,58)=20.8,
p,.0001) but not for Treatment (F(2,58)=1.94, p=.17), with a
significant interaction between Lens Defocus and Treatment
(F(2,58)=5.5, p=.007) (see Fig 1C). Further, barium did not show
a lens-dependant effect on anterior chamber depth (correlation
r^2=.048). Figure 1B indicates that an effective intravitreal
concentration of 5mM barium chloride, which would be expected
to non-selectively block potassium channels, inhibited refractive
compensation for both positive and negative lens defocus but did
not generally inhibit vitreal growth. A comparison of vitreal
chamber lengths between Ba
2+ and SAL eyes, taken across all lens
groups, showed no significant difference (difference of
means=0.098 mm, Fisher’s PLSD, p=.26) - see Table 1.
Experiment 2: Effect of the loop diuretic bumetanide
In hatchling chicks, bumetanide suppressed refractive compen-
sation to negative lenses in a dose specific fashion (here the two
effective vitreal concentrations are referred to as Bum1=10
25M,
Bum2=5610
26M), but did not significantly affect refractive
compensation to optical defocus of +10D or to zero power lenses
(see Table 2). A scatter plot (Fig 2A) demonstrates the general
negative linear relationship between refraction and vitreous
Figure 1. The effect on refractive and growth compensation of blocking retinal and RPE potassium channels with intravitreal Ba
2+
ion at an effective concentration of 5mM. A. Scatter plot of Refraction in dioptres versus Vitreous Chamber depth (mm). across all eyes
measured. The applied defocus is indicated by the triangles or circle symbols, with green symbols indicating Ba
2+ and blue symbols indicating saline
injected eyes. B. Refractions of eyes injected with Ba
2+ compared with those injected with similar volume of Saline. Compensation in Ba
2+ eyes is
suppressed for both positive and negative lens defocus. The same colour code applies as for A. C. Vitreous chamber depths of Ba
2+ and SAL eyes. An
inverse relationship between vitreous chamber depth and refraction is evident. The same colour code applies as for A. The effect of defocus on VC
depth is much less for Ba
2+ than for SAL eyes, however the mean VC depth for Ba
2+ eyes averaged over all lens groups is very similar to that for SAL
eyes. This indicates that Ba
2+ does not inhibit eye growth per se, but suppresses compensation to defocus-related eye growth. Data presented as
means6SE.
doi:10.1371/journal.pone.0002839.g001
Table 1. Means Tables and Post-hoc comparisons Ba
2+ vs SAL for Ocular Refraction and Vitreous Chamber Depth
Rx Ba2+ (D) Rx SAL (D) Fisher’s PLSD
Lens Mean SE Mean SE p
210D 22.88 0.86 28.59 0.93 0.0002
0D 22.33 1.18 0.49 1.08 0.09 ns
+10D 2.77 1.28 8.23 0.91 ,.0001
Lens VC Ba2+ (mm) VC SAL (mm) Fisher’s PLSD
Mean SE Mean SE p
210D 5.39 0.07 5.61 0.09 0.024
0D 5.31 0.08 5.08 0.11 0.11 ns
+10D 5.10 0.08 4.82 0.09 0.04
doi:10.1371/journal.pone.0002839.t001
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small differences in this relation between drug groups. This is most
easily observed for the Bum2 (open red symbols) compared with
SAL (filled blue symbols), where linear regression shows parallel
slopes of approximately 214D/mm, but with the Bum2 data offset
by 0.18mm, i.e. with greater VC depth for the same refraction.
A between groups ANOVA (for Lens Defocus (+10D, 0D,
210D) and Treatment (Bum1, Bum2, Saline)) indicated significant
main effects for Ocular Refraction of Treatment (F(2, 98)=4.5,
p=.0135), Lens Defocus (F(2, 98)=177, p,.0001) and a
significant Treatment*Lens Defocus interaction (F(4, 98)=3.6, p
,.01). At the higher concentration of bumetanide (Bum1:
10
25M), there was a significant difference in refractive compen-
sation to negative lens defocus between the bumetanide and
control Saline injected eyes (Bum1: 22.4261.17 D, SAL:
28.5960.93 D; Fisher’s PLSD:, p=.0002–see Fig 2B). Rearing
with 210D lenses, the higher dose of bumetanide resulted in a
sparing of over 6 D of refractive compensation compared with the
Saline group, while the lower dose was markedly less effective
(25.360.74 D). Post-hoc tests also indicate that the higher dose is
significantly more effective than the lower dose (Fisher’s PLSD:
mean difference=2.9 D, p=.0033). Indeed, further post-hoc
testing within the separate lens rearing groups (see Table 2)
indicates that bumetanide only significantly affects refractive state
in the negative lens reared chickens.
Axial dimension of the vitreous chamber of the three negative
lens wearing groups also show significant differences (see Fig 2C).
ANOVA indicates a main effect of Treatment (2 doses of
bumetanide, saline) (F(2,96)=3.64, p=.03) and lens
(F(2,96)=30.1, p,.0001), while the Treatment*Lens Defocus
interaction was not significant. Thus, eyes injected intravitreally
with bumetanide, showed a slightly greater vitreal chamber depth
Figure 2. The effect on refractive compensation of the loop diuretic bumetanide at two concentrations in the vitreous chamber
compared with control saline injections. Bum1 refers to an effective vitreal concentration of 10
25 M, Bum2 refers to an effective concentration
of 5610
26 M. A. Scatter plot of Refraction in dioptres versus Vitreous Chamber depth (mm) across all eyes measured. The applied defocus is
indicated by the triangles or circle symbols, with red filled symbols indicating Bum1, red open symbols indicating Bum2 and blue symbols indicating
saline injected eyes. B. Compensation to negative lens rearing markedly diminished for both bumetanide doses with the higher dose (Bum1)
resulting in approximately 6D less refractive compensation than for SAL. The same colour code applies as for A. The refractive effect is specific to the
induction of myopia, with 0D and +10D groups showing no significant effect of the intravitreal diuretic. C. Vitreous chamber depths of bumetanide
and saline injected eyes. The same colour code applies as for A. While the same trend as in A is evident with a dose dependency with negative lens
defocus, it can also be seen that mean VC depth is slightly larger for Bumetanide cf SAL eyes, especially for 0D and +10D groups. Data presented as
means6SE.
doi:10.1371/journal.pone.0002839.g002
Table 2. Means Tables and Post-hoc comparisons Bum1, Bum2 vs SAL for Ocular Refraction and Vitreous Chamber Depth
Rx Bum1 (D) Rx Bum2 (D) Rx SAL (D) Bum1 v SAL Bum2 v SAL
Lens Mean SE Mean SE Mean SE PLSD p PLSD p
210D 22.42 1.17 25.27 0.74 28.59 0.93 0.0001 0.01
0D 1.33 0.99 1.12 1.10 0.49 1.08 0.61 ns 0.68 ns
+10D 8.02 0.70 7.75 0.46 8.23 0.91 0.87 ns 0.69 ns
VC Bum1 (mm) VC Bum2 (mm) VC SAL (mm) Bum1 v SAL Bum2 v SAL
Lens Mean SE Mean SE Mean SE PLSD p PLSD p
210D 5.45 0.06 5.66 0.04 5.61 0.09 0.12 ns 0.53 ns
0D 5.27 0.12 5.37 0.08 5.08 0.11 0.17 ns 0.03
+10D 5.08 0.11 5.05 0.08 4.82 0.09 0.06 ns 0.08 ns
doi:10.1371/journal.pone.0002839.t002
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saline, measured over all Lens groups (see Table 2). Post-hoc
comparisons within Lens defocus groups were not significant,
except for 0D defocus with the lower dose of bumetanide. Anterior
chamber depths were not affected in a sign-dependant fashion,
with a low correlation found between AC depth and applied
defocus (r^2=.01).
The fellow eyes demonstrated similar refractive states across all
drug and lens groupings of the experimental eyes. Anterior
chamber depths of fellow eyes also did not show systematic
differences with respect to the various experimental eye groups.
Discussion
The experiments reported here demonstrate that both unselec-
tive blocking of potassium channels and selective inhibition of the
sodium-potassium-chloride symporter can produce dramatic
interference with refractive compensation to optically induced
blur. As both subretinal [K] and the activity of the NKCC1
symporter of the apical membrane of the RPE (and the
photoreceptor/ON bipolar synapse) are known to affect the
shunting of fluid between the retina and the choroid [9,11] these
results are consistent with a mechanism of ocular growth and
refractive error based on alteration in the rates of ionically
controlled transretinal fluid flow, (particularly by Na, K and Cl, -
the major ions of phototransduction and cell volume regulation),
as originally hypothesized by Crewther [6]. A chief tenet of this
theory of refractive and growth control is that alteration in outer
retinal visual activity under conditions of defocus leads to changes
in the ionic contents of the subretinal space (depending on the sign
and degree of defocus). To date, the only published data relating
myopia to ionic changes are restricted to K, Na and Cl
abundances [15] . If, as postulated, [K
+]SRS is central to refractive
control [6,15], the effects of potassium on the RPE apical NKCC
cotransporter and inward rectifying K channels [24,30] in
modulating chloride (and water) transfer across the RPE need to
be better understood before pharmaceutical management of
myopia can be achieved.
As expected, intravitreal injection of barium severely inhibited
refractive compensation to both plus and minus lenses. This could
be interpreted as a Ba
2+ induced suppression of visual function,
although electrophysiological evidence suggests otherwise, at least
in terms of outer retinal function. In rabbit, acute injection of Ba
2+
induced an augmentation of the b-wave of the electroretinogram,
at least in the short term, while over longer post injection periods
the amplitude diminishes [34]. Barium would also be expected to
affect aqueous humor secretion and intraocular pressure [35],
though our results show no systematic change in anterior chamber
depth between the experimental and fellow eyes of the various lens
groups. Vitreous chamber depth in all three lens groups was also
similar after barium injections, suggesting that nonspecific
blockade of potassium channels in the eye inhibits differential
ocular growth and refractive compensation to applied defocus. On
the other hand our biometric measurements also indicate that
barium does not actually stop the eyeball growing.
By comparison the results following raising in the presence of
bumetanide are more interesting and less simple to interpret. As
expected, we found main effects of lens defocus and drug
treatment on refraction and vitreous chamber with a significant
defocus/treatment interaction for ocular refraction. However, the
general VC elongation seen with bumetanide (except for the
higher dose with 210D lens rearing) was slightly unexpected. It
appears that a model to explain the data should include a defocus
independent elongation effect as well as a defocus dependent effect
on refractive compensation and vitreous chamber depth that
applies under conditions of negative lens defocus.
We suggest that the most parsimonious interpretation of the
success of bumetanide in inhibiting the degree of induced myopia
under –ve lens defocus conditions is that the apical RPE and ON-
bipolar NKCC1 cotransporters have changed their mean
operating conditions, and hence net fluid transport. Currently, it
is accepted that when [K+]SRS is raised from 2mM to 5mM, RPE
basal to apical
36Cl
2 flux increases dramatically, while the apical
to basal
36Cl
2 flow is relatively unchanged, leading to a net
secretion rather than absorption of chloride and the slowing of
outflow, attributed to the NKCC1 cotransporter and basal
NaHCO3 [30]. Fluid transport is reduced by 25% under these
conditions. The reverse chloride movement was hypothesized to
involve a compensatory bicarbonate transport. Fluid flow in the
dark [22] and under FD conditions [6] has also been hypothesized
to decrease due to the reaccumulation of subretinal potassium.
The NaK-ATPase which maintains the potential difference across
the RPE must also maintain its activity to maintain the outflow
[9]. This activity is dependent on [K]SRS, but so also is the
cotransport of Na-K-Cl [18]. A bumetanide induced reduction in
RPE outflow is also a likely cause of the increase in VC depth
observed in the bumetanide injected eyes reared with 0D
and+10D lenses, given that aqueous humour production and
intraocular pressure changes under bumetanide are minimal (at
least in mouse and monkey [36,37]).
The situation with –ve lens rearing is somewhat different.
Defocus together with patterned stimulation results in lowered
amplitude of temporal modulation, particularly at high spatial
frequencies. Thus, with patterned stimulation, an apical NKCC1
symporter should shunt ions and fluid back and forth between the
SRS and the interior of the RPE cell under a sequence of light/
dark transitions. The net fluid flow actually generated across the
apical membrane of the RPE would be dependant on the
modulation of [K] in the SRS and on the time constant for water
transport of the receptor mechanism and the relation between
water and ion transfer [24]. It has been suggested [6] that
defocused pattern stimulation results in a sign-dependant asym-
metry in the profile of temporal modulation of the photoreceptors.
Hence, as the SRS volume changes are relatively slower than the
ionic changes [38], the slower phase of the asymmetric temporal
profile of onset or offset will likely drive more fluid than the faster
phase. Averaged across the RPE under patterned defocused
stimulation, a net reduction in outflow could result if the reverse
flow probability was thus biased. The net flow reduction would
explain the abnormal axial elongation and myopia. The effect of
bumetanide block of the NKCC1 is to prevent this reversal
occurring and hence inhibiting the myopic response to –ve lens
defocus and also increasing the rate of flow across the RPE to the
choroid. In support of involvement of the NKCC1 transporter in
these fluid flow changes, it has been reported [38] that bumetanide
inhibits the light evoked volume increase in the subretinal space.
Bumetanide, as a selective NKCC1 inhibitor, would be
expected to affect the ciliary secretion of Na, K, and Cl ions
[36], as well as the targeted apical membrane of the RPE and ON
bipolar dendrites. However, as we saw insignificant effects of
bumetanide on anterior eye parameters, such effects on the ciliary
body can be considered independent of the applied lens defocus.
Certainly, light-induced changes in potassium concentration in the
subretinal space are enhanced by the application of bumetanide
[38], although this may be due in part to the concomitant
inhibition of the light-induced SRS volume increase [11]. At high
concentrations (0.5mM), bumetanide is reported to inhibit the b-
wave of the electroretinogram (ERG) in fish eye cup [39], but the
Control of Myopia
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used here. Thus, it is unlikely that the effects of blocking the
NKCC1 on negative lens defocus, i.e. of inhibiting the
development of myopia, are due to any major compromise of
outer retinal function. The strong similarity in refractive
compensation under +ve lens defocus conditions between
bumetanide and saline injected eyes suggests that the bumetanide
treated retina is functioning relatively normally under those
defocus conditions. As referenced in the introduction, other studies
(TTX elimination of spiking neuronal responses, optic nerve
section, etc) suggest that considerable damage to inner retinal
function can be sustained without compromising refractive
compensation ability.
To date there is very little consideration in the literature of the
action of bumetanide on the NKCC1 cotransporters on the ON-
bipolar dendrites. It would be expected that with bumetanide
block, any response to the onset of light, whether in the presence of
optical blur or not, would result in a lesser influx of K, Na and Cl
ions into the ON bipolars and hence a greater abundance of ions
in the extracellular space, increased osmotic gradients and so draw
further water out of the cells and increase the need for greater
transport of fluid out of the inner retina and across the RPE to the
choroid.
Furthermore, it is curious that the effects of bumetanide in
primarily inhibiting compensation to –ve lens defocus is
reminiscent of similar findings relating alteration of the ON and
OFF response and sign-dependant interference with compensa-
tion. This interference occurs if the retinal response is environ-
mentally altered through sawtooth illumination [40] or altered
through pharmacological blockade of the retinal ON and OFF
responses via the use of L- or D-a-aminoadipic acid (LAA and
DAA) [41]. Similarly, mouse mutants with an ON pathway defect
[42] show increased susceptibility to FDM. The coincidence of
findings is more salient because it is the blockade of the ON-
response (with LAA) that interferes selectively with ocular growth
and refractive compensation to –ve lens defocus.
Thus barium, a potassium channel blocker inhibits compensa-
tion to defocus of both signs, while bumetanide, a common loop
diuretic approved for human use, demonstrates a selective
inhibition on negative lens defocus induced refractive change in
the chick. The action of bumetanide appears to combine a
defocus-sensitve inhibition of refractive compensation under
conditions that would normally lead to myopia, plus a small
defocus-insensitive effect on vitreous chamber depth. Given the
common channels and symporters on the RPE demonstrated by
many animals, including human, there is hope that a rapid
development path to a pharmaceutical control of myopia can be
established, especially important for the increased incidence
observed recently in Asia [43].
Materials and Methods
Animals
A total of 139 male hatchling chicks of the Leghorn/Australorp
strain were raised in a light and temperature controlled box with
ad libitum food and water and illumination provided by a static
40W pearl incandescent light bulb on a 12 hour day/night cycle.
On day 6, all chicks were anaesthetized with an intramuscular
injection of a mixture of ketamine/xylazine (45 mg.kg
21/
4.5 mg.kg
21 i.m.) prior to monocular intravitreal (5 ml) injections
of either saline (n=32), barium chloride (vitreal concentration
5mM in saline, n=33) or bumetanide (vitreal concentration
10
25M (Bum1), n=31, or 2610
26M (Bum2), n=43, dissolved in
saline and monocular attachment of lenses. All fellow eyes were
injected with 5 ml of saline. The initial concentrations of barium
and bumetanide used were determined on the basis of previous
work [38] and electroretinographic recordings. Doses of drugs are
presented as estimated vitreal concentrations. These estimates
were calculated using a vitreous volume of 0.5 ml and assuming
complete mixing. However, it is acknowledged that mixing will not
be rapid, as the diffusion coefficient through the gel vitreous will be
considerably less than that through the sol vitreous. Hence the
actual release of drug is likely to be more gradual. While the
concentration half-life of the two drugs used here has not been
quoted, various therapeutic agents demonstrate vitreous half-lives
of 2.5–5 day (e.g. [44]).
Chicks were randomly assigned to one of the goggle wearing
groups (+/210D or 0D PMMA human contact lenses). Lenses
were attached to a ring of Velcro glued to the periocular feathers.
The field of view through the goggle was ,90
0. Animals and lenses
were checked and cleaned twice daily. To control for batch
variation, each batch included chicks from each of the three lens
groups to allow more valid comparison.
Biometry
On Day 10, biometric measurements including retinoscopy and
ultrasonography were made on all animals under general
anaesthesia (which induces adequate pupillary dilation and negates
the need for topical mydriasis). Refractions were recorded as
equivalent spherical power. A-scan ultrasonography (Ophthascan:
7MHz) was performed and axial length and vitreous chamber
depths were determined. Animals were killed by anaesthetic
overdose after biometric measurements were completed.
All animals were raised in accordance with the ARVO
Convention and the Australian NHMRC guidelines on Animal
Use in Research. Institutional Ethics approval for the experimen-
tation was obtained from the Animal Ethics Committee at La
Trobe University, Melbourne, Victoria Australia.
Data Analysis
Between group statistical comparisons of refractions and axial
dimensions were made using Analyses of Variance (ANOVA) and
relevant post hoc tests as required. The effects of drugs on the non-
lensed fellow eyes were also assessed
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